Augmentation procedure failure · Patients undergoing lateral-window maxillary sinus lift
1 finding from 1 review
Safety of the intervention (adverse effects) · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Hamuryudan 1998: significant adverse effects including severe sedation, polyneuropathy, loss of libido, and weight gain; a greater number of adverse events was seen for the higher (300 mg) dose; 4 patients withdrew due…
1 study · 101 participants
GRADE not reported
Implant failure · Patients with insufficient bone below the maxillary sinus requiring dental implants
One-stage augmentation (implants placed simultaneously) showed no clear difference in implant failure compared with two-stage augmentation (delayed implant placement); GRADE not reported.
1 finding from 1 review
Complications · Patients undergoing crestal maxillary sinus lift
Osteotomes with mallet (Summers' technique) showed no clear difference in complications compared with rotary instruments (Cosci technique); GRADE not reported.
1 finding from 1 review
Number of painful days · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
Sucralfate suspension (topical) showed no clear difference in number of painful days compared with placebo suspension; GRADE not reported.
1 finding from 1 review
Augmentation procedure failure · Patients undergoing one-stage crestal maxillary sinus lift without bone grafts (baseline residual bone height about 6.5 mm)
1 finding from 1 review
Prosthesis failure · Patients with 2 to 7 mm of residual alveolar bone height in the edentulous maxillary sinus floor
One-stage lateral sinus lift with monocortical autogenous bone… showed no clear difference in prosthesis failure compared with two-stage lateral sinus lift with autogenous particulate bone (iliac…; GRADE not reported.
1 finding from 1 review
Complications · Patients with an atrophic maxillary sinus requiring augmentation (1 to 5 mm residual bone height)
Sinus lift with bone graft (granular Bio-Oss) showed no clear difference in complications compared with sinus lift without bone graft (Inion resorbable rigid barrier…; GRADE not reported.
1 finding from 1 review
OR 0.50 [0.01, 9.60]
1 study · 9 participants
GRADE not reported
Implant failure · Patients undergoing lateral-window maxillary sinus lift
1 finding from 1 review
Complication at augmented site · Patients undergoing one-stage crestal maxillary sinus lift without bone grafts (baseline residual bone height about 6.5 mm)
Hand mallet (osteotomes) showed no clear difference in complications at augmented site compared with electric mallet; GRADE not reported.
1 finding from 1 review
Implant failure · Patients with an atrophic posterior maxilla requiring maxillary sinus augmentation
Autogenous bone graft (two-stage lateral sinus lift) showed no clear difference in implant failure compared with bone substitute (anorganic bovine bone / Bio-Oss); GRADE not reported.
1 finding from 1 review
Implant failure · Patients with insufficient bone below the maxillary sinus requiring dental implants
1 finding from 1 review
No statistically significant difference for implant failures. Per trial: Raghoebar 2005 1 failure in the PRP arm, OR 3.67 (0.12 to 113.73), P = 0.46; Torres 2009 (PRP only = 1, no-PRP only = 2), OR 0.50 (0.01 to…
2 studies · 62 participants
GRADE not reported
Prosthesis failure · Patients undergoing two-stage maxillary sinus augmentation
1 finding from 1 review
Lindgren 2012 (split-mouth, 11 patients): prosthesis failures 0/11 versus 0/11; none.
1 study · 11 participants
GRADE not reported
Augmentation procedure failure · Patients with an atrophic maxillary sinus requiring augmentation (1 to 5 mm residual bone height)
Sinus lift with bone graft (granular Bio-Oss) showed no clear difference in augmentation procedure failure compared with sinus lift without bone graft (Inion resorbable rigid barrier…; GRADE not reported.
1 finding from 1 review
Number of (minor aphthous) oral ulcers · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Hamuryudan 1998 (thalidomide 100 mg or 300 mg daily vs placebo, 101 male patients; high risk of reporting bias): a significant effect on mean numbers of minor oral ulcers was reported from week 4 in both thalidomide…
1 study · 101 participants
GRADE not reported
Complication at augmented site · Patients undergoing lateral-window maxillary sinus lift
Rotary instruments to open the lateral sinus window showed no clear difference in complications at augmented site compared with piezosurgery to open the lateral sinus window; GRADE not reported.
1 finding from 1 review
Oral ulcers (number, size, healing time) · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Ergun 1997 (cyclosporin A in orabase vs placebo orabase, 24 patients; high risk of reporting bias): no data were presented; authors reported no clinical improvement in the number, size, and healing time of ulcers for…
1 study · 24 participants
GRADE not reported
Prosthesis failure · Patients with insufficient bone below the maxillary sinus requiring dental implants
One-stage augmentation (implants placed simultaneously) showed no clear difference in prosthesis failure compared with two-stage augmentation (delayed implant placement); GRADE not reported.
1 finding from 1 review
Safety of the intervention (adverse effects) · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Alpsoy 2002: high rate of adverse events including alopecia, leukopenia, and diarrhoea; 18 of 23 patients in the treatment arm experienced mild flu-like symptoms.
1 study · 50 participants
GRADE not reported
Complication at augmented site · Patients undergoing two-stage maxillary sinus augmentation
Bone substitute (anorganic bovine bone / Bio-Oss) showed no clear difference in complications at augmented site compared with A different bone substitute; GRADE not reported.
1 finding from 1 review